Skip to main content
. 2014 May 1;3(3):16–24. doi: 10.7453/gahmj.2014.019

Table 6.

Demographic Information of Rifaximin vs Herbal Users

Rifaximin (n=67) Herbal (n=37) P value
Age (yrs) 47.55 ± 15.73 41.6 ± 16.3 .07
Percent female 48 (71%) 29 (78%) .45
Risk Factors for SIBO 9 (13%) 7 (19%) .46
Diabetes mellitus 4 (6%) 0 (0%) .12
Gastroparesis 2 (3%) 1 (3%) .93
Narcotic 1 (1%) 3 (8%) .09
CTD 2 (3%) 4 (11%) .1
Any risk factor 9 (13%) 7 (19%) .46
IBS 53 (79%) 25 (68%) .19
Distribution of IBS by Subtypes .08
None 14 (21%) 12 (32%)
Diarrhea predominant 22 (32%) 6 (16%)
Constipation predominant 16 (24%) 12 (32%)
Mixed 14 (21%) 4 (11%)
Unclassified IBS 1 (1%) 3 (8%)
Negative LBT after Rx 23 (34%) 17 (46%) .24